Xu Y - Search Results

1

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer.

Zhou Q, Xu J, Xu Y, Sun S, Chen J. Zhou Q, et al. Among authors: xu y, xu j. Front Immunol. 2023 Aug 21;14:1176647. doi: 10.3389/fimmu.2023.1176647. eCollection 2023. Front Immunol. 2023. PMID: 37671167 Free PMC article.

2

Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma.

Zhou Q, Xu Y, Shen L, Yang X, Wang L. Zhou Q, et al. Among authors: xu y. Front Oncol. 2022 Sep 5;12:852365. doi: 10.3389/fonc.2022.852365. eCollection 2022. Front Oncol. 2022. PMID: 36132130 Free PMC article.

3

Increased Stromal Infiltrating Lymphocytes are Associated with Circulating Tumor Cells and Metastatic Relapse in Breast Cancer Patients After Neoadjuvant Chemotherapy.

Liu J, Xu Y, Yu M, Liu Z, Xu Y, Ma G, Zhou W, Kong P, Ling L, Wang S, Pan H, Zhao Y. Liu J, et al. Among authors: xu y. Cancer Manag Res. 2019 Dec 27;11:10791-10800. doi: 10.2147/CMAR.S220327. eCollection 2019. Cancer Manag Res. 2019. PMID: 31920388 Free PMC article.

4

NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple-negative breast cancer by blocking the EGFR pathway.

Sang R, Yu X, Xia H, Qian X, Yong J, Xu Y, Sun Y, Yao Y, Zhou J, Zhuo S. Sang R, et al. Among authors: xu y. Mol Carcinog. 2024 Apr;63(4):785-796. doi: 10.1002/mc.23688. Epub 2024 Jan 30. Mol Carcinog. 2024. PMID: 38289126

5

Stem cells as potential therapeutics for hearing loss.

Fang Q, Wei Y, Zhang Y, Cao W, Yan L, Kong M, Zhu Y, Xu Y, Guo L, Zhang L, Wang W, Yu Y, Sun J, Yang J. Fang Q, et al. Among authors: xu y. Front Neurosci. 2023 Sep 7;17:1259889. doi: 10.3389/fnins.2023.1259889. eCollection 2023. Front Neurosci. 2023. PMID: 37746148 Free PMC article. Review.

6

SLC35A2 expression drives breast cancer progression via ERK pathway activation.

Yang X, Tao Y, Xu Y, Cai W, Shao Q. Yang X, et al. Among authors: xu y. FEBS J. 2024 Apr;291(7):1483-1505. doi: 10.1111/febs.17044. Epub 2024 Jan 9. FEBS J. 2024. PMID: 38143314

7

WSCD2 Expression: Its Relevance to Tumor-Infiltrating Immune Cells and Glioma Prognosis.

Abudusalam K, Xu Y, Keyumu P, Cheng T, Xu M, Lu B, Sun P, Musha K, Huang J. Abudusalam K, et al. Among authors: xu m, xu y. Curr Med Chem. 2024 Feb 26. doi: 10.2174/0109298673282921240220101914. Online ahead of print. Curr Med Chem. 2024. PMID: 38415455

8

XIST/miR-34a-5p/PDL1 axis regulated the development of lung cancer cells and the immune function of CD8⁺ T cells.

Li J, Che L, Xu C, Lu D, Xu Y, Liu M, Chai W. Li J, et al. Among authors: xu c, xu y. J Recept Signal Transduct Res. 2022 Oct;42(5):469-478. doi: 10.1080/10799893.2021.2019274. Epub 2022 Jan 23. J Recept Signal Transduct Res. 2022. PMID: 35067156

9

Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases.

Sun X, Zang YS, Xu Y, Wang W. Sun X, et al. Among authors: xu y. Front Med (Lausanne). 2024 Sep 5;11:1470068. doi: 10.3389/fmed.2024.1470068. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39301486 Free PMC article.

10

Mendelian randomization analyses of genetically predicted circulating levels of cytokines with risk of breast cancer.

Li S, Xu Y, Zhang Y, Nie L, Ma Z, Ma L, Fang X, Ma X. Li S, et al. Among authors: xu y. NPJ Precis Oncol. 2020 Sep 1;4:25. doi: 10.1038/s41698-020-00131-6. eCollection 2020. NPJ Precis Oncol. 2020. PMID: 32923685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,506 results

Search Page

Filters